Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Gyre Therapeutics (GYRE) over the last 15 years, with Q3 2025 value amounting to $5.3 million.

  • Gyre Therapeutics' Other Non-Current Assets rose 9240.78% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 9240.78%. This contributed to the annual value of $6.3 million for FY2024, which is 53115.58% up from last year.
  • According to the latest figures from Q3 2025, Gyre Therapeutics' Other Non-Current Assets is $5.3 million, which was up 9240.78% from $5.3 million recorded in Q2 2025.
  • Over the past 5 years, Gyre Therapeutics' Other Non-Current Assets peaked at $6.3 million during Q4 2024, and registered a low of $168000.0 during Q2 2022.
  • Over the past 5 years, Gyre Therapeutics' median Other Non-Current Assets value was $869000.0 (recorded in 2021), while the average stood at $1.9 million.
  • In the last 5 years, Gyre Therapeutics' Other Non-Current Assets tumbled by 8562.87% in 2022 and then surged by 154642.86% in 2024.
  • Over the past 5 years, Gyre Therapeutics' Other Non-Current Assets (Quarter) stood at $472000.0 in 2021, then surged by 619.07% to $3.4 million in 2022, then plummeted by 70.68% to $995000.0 in 2023, then skyrocketed by 531.16% to $6.3 million in 2024, then fell by 15.25% to $5.3 million in 2025.
  • Its last three reported values are $5.3 million in Q3 2025, $5.3 million for Q2 2025, and $5.6 million during Q1 2025.